An article published in the August 5, 2008, issue of the Proceedings of the National Academy of Sciences reported that injections of ascorbate (vitamin C) reduce the weight and growth rate of tumors by half in mouse models of ovarian, pancreatic and brain cancer, while leaving normal cells unharmed.
Researchers at the National Institutes of Health (NIH) tested ascorbate in 43 tumor and 5 normal cell lines to determine a concentration that decreases cell survival in cancerous cells without resulting in toxicity to healthy cells. They subsequently injected a dose of 4 grams ascorbate (neutralized with sodium hydroxide) per kilogram body weight once or twice per day into immune-deficient mice with implanted ovarian, pancreatic and glioblastoma (brain) tumors. "At these high injected doses, we hoped to see drug-like activity that might be useful in cancer,” explained lead author Mark Levine, MD, who is the chief of the Molecular and Clinical Nutrition Section of the National Institute of Diabetes and Digestive and Kidney Diseases at the NIH.
Dr Levine’s team found that injecting the animals with ascorbate decreased tumor growth and weight by 41 to 53 percent. While metastases occurred in 30 percent of the mice with brain tumors, none appeared in animals injected with vitamin C. No adverse effects of vitamin C treatment were noted.
Interestingly, vitamin C, which is known for its antioxidant effect, achieved the current study’s results via a pro-oxidant effect that can occur at high levels. This effect causes the formation of hydrogen peroxide in the extracellular fluid surrounding the tumors (but not in the blood), resulting in the death of cancerous cells. The vitamin was administered by injection in the current study in order to achieve high concentrations in the body that cannot be reached using an oral route.
Blood levels of ascorbate similar to those measured in the mice have been readily achieved in human subjects who received intravenous vitamin C. The authors suggest that the failure of double-blind placebo-controlled trials of vitamin C in cancer patients, which were conducted following initial encouraging case series results, could be due to the oral route of administration used in the trials.
“Clinical and pharmacokinetic studies conducted in the past 12 years showed that oral ascorbate levels in plasma and tissue are tightly controlled,” Dr Levine observed. “In the case series, ascorbate was given orally and intravenously, but in the trials ascorbate was just given orally. It was not realized at the time that only injected ascorbate might deliver the concentrations needed to see an anti-tumor effect."
"These preclinical data provide a firm basis for advancing pharmacologic ascorbate in cancer treatment in humans," the authors write. “As modalities in cancer are often combined, these data suggest that pharmacologic ascorbate in combination with other therapies deserves further exploration for treatment of cancers that otherwise have poor outcomes, such as pancreatic and ovarian carcinomas and glioblastoma.”
Little is known about the causes of pancreatic cancer. The disease is difficult to diagnose in its early stages, as it presents few symptoms and there are few tests to screen for it. As a result, most patients have incurable disease by the time they are diagnosed. Fewer than 5 percent of pancreatic cancer patients survive five years beyond diagnosis of the disease. Surgery is the only hope for cure; however, due to the aggressive nature of pancreatic tumors, only 5 percent to 20 percent of patients are candidates for surgery (Cleary SP et al. 2004). Chemotherapy and radiation therapy produce only minor increases in survival rates. Conventional medicine's inability to treat pancreatic cancer effectively is illustrated by the fact that more than 90 percent of patients die within 12 months of diagnosis. Along with lifestyle changes and nutritional approaches, novel therapeutic strategies are needed for the treatment of pancreatic cancer.
Risk Factors for Pancreatic Cancer
Age, sex, race, and ethnicity. The disease is more common in the elderly and among men, and there is a higher incidence rate among African-Americans (Ghadirian L et al 2003).
Smoking (Lowenfels AB et al 2002; Michaud DS 2004).
Exposure to chemicals such as gasoline, petroleum products, and DDT (Alguacil J et al 2003; Hoppin JA et al 2000; Simon B et al 2001).
Inherited pancreatic disease and inherited breast cancer (Cowgill SM et al 2003; Ghadirian P et al 2003; Lowenfels AB et al 2004).
Chronic pancreatitis and diabetes mellitus (Truninger K 2000).
Insulin resistance (Berrington de Gonzalez A et al 2003).
Diet: excess calorie intake; high intake of saturated fats and oils, including omega-6 fatty acids, meat, and dairy products; and high intake of fried foods, carbohydrates, cholesterol, salt, nitrites from animal products, and nitrosamines (Coss A et al 2004).
Start planning your 2009 vacation with these two fantastic specials:
EARLY BIRDS TO CANCUN IN 2009 WITH MEXICANA We have partnered with Mexicana Airlines to offer exclusive rates on daily non-stop flights to Cancun departing from Miami (from $379), Los Angeles (from $449), New York (from $479) and Chicago (from $599). Round trip, taxes and fees included.
ONE WEEK FOR A GROUP OF FOUR, ONLY $399 (land only) Enjoy a week’s stay for four in one of our showcase resort destinations selected for the variety of activities they offer.
– New Hampshire
– Dominican Republic
– South Carolina
* Rates are in US dollars. Based upon availability. Subject to change without notice. Other restrictions may apply.
Since 1981, several hundred studies have been published on DHEA’s various benefits, including immunomodulatory properties as well as positive effects on mood, quality of life, and body composition. It has been proposed that restoring the circulating levels of DHEA to those found in young people may improve well-being and sexual function. In a recent randomized, double-blind, placebo-controlled study, ten months of DHEA replacement therapy has the beneficial effect of enhancing the increases in muscle mass and strength with the addition of resistance exercise in elderly individuals. The studies of DHEA therapy in women with adrenal insufficiency also suggest beneficial effects on well-being, mood, and sexuality. DHEA could be of benefit to the normal aging brain. Some studies have reported DHEA may improve mood and alleviate melancholy. In addition, recent studies in vitro have shown that DHEA has the capacity to improve endothelial function by increasing nitric oxide (NO) synthesis.
A large percentage of men over age 50 suffer from prostate-induced discomforts. The Ultra Natural Prostate Formula contains the most scientifically substantiated nutrients to help protect the prostate gland and maintain its healthy function.
Recently added to the formulas are standardized lignans from flax and the Norway spruce trees. These lignans convert to enterolactones in the intestine that are then absorbed into the bloodstream where they provide significant biological effects. Enterolactones have demonstrated antiestrogen and anti-DHT effects that are of particular importance for the aging prostate gland.